AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 49 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,728 | -14.9% | 1,129,189 | -8.2% | 0.00% | 0.0% |
| Q2 2023 | $2,030 | +243.5% | 1,230,196 | +137.1% | 0.00% | +200.0% |
| Q1 2023 | $591 | +41.7% | 518,800 | +12.1% | 0.00% | 0.0% |
| Q4 2022 | $417 | -100.0% | 462,737 | -48.6% | 0.00% | 0.0% |
| Q3 2022 | $1,054,000 | +34.3% | 900,800 | -26.5% | 0.00% | 0.0% |
| Q2 2022 | $785,000 | +772.2% | 1,226,400 | +3475.5% | 0.00% | – |
| Q1 2022 | $90,000 | +104.5% | 34,300 | +204.7% | 0.00% | – |
| Q4 2021 | $44,000 | -94.7% | 11,257 | -94.1% | 0.00% | -100.0% |
| Q3 2021 | $827,000 | -15.1% | 189,669 | -22.7% | 0.00% | 0.0% |
| Q2 2021 | $974,000 | -33.0% | 245,448 | -9.7% | 0.00% | -50.0% |
| Q4 2020 | $1,454,000 | +125.8% | 271,800 | -7.6% | 0.00% | +100.0% |
| Q1 2020 | $644,000 | +40.0% | 294,051 | +272.2% | 0.00% | – |
| Q4 2019 | $460,000 | – | 79,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $55,848,000 | 77.67% |
| Bracebridge Capital, LLC | 428,571 | $2,083,000 | 0.33% |
| Oak Grove Capital LLC | 89,000 | $432,000 | 0.20% |
| Perceptive Advisors | 1,750,000 | $8,496,000 | 0.12% |
| Virtu Financial LLC | 117,206 | $569,000 | 0.10% |
| WEDBUSH SECURITIES INC | 103,240 | $501,000 | 0.05% |
| J. Goldman & Co LP | 117,600 | $571,000 | 0.04% |
| Engineers Gate Manager LP | 68,300 | $332,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 118,900 | $577,000 | 0.01% |
| Brandywine Global Investment Management, LLC | 137,029 | $666,000 | 0.01% |